Accessibility Menu
 
OncoSec Medical logo

OncoSec Medical

(OTC) ONCSQ

Current Price$0.00
Market CapN/A
Since IPO (2010)-100%
5 Year-100%
1 Year+0%
1 Month+0%

OncoSec Medical Financials at a Glance

Market Cap

N/A

Revenue (TTM)

$0.00

Net Income (TTM)

$29.39M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-1784.20 (Low)

Price

$0.00

Volume

2

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

ONCSQ News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About OncoSec Medical

Industry

Biotechnology

Employees

41

CEO

Robert H. Arch, PhD

Headquarters

Pennington, NJ 08534, US

ONCSQ Financials

Key Financial Metrics (TTM)

Gross Margin

0%

Operating Margin

0%

Net Income Margin

0%

Return on Equity

0%

Return on Capital

-2%

Return on Assets

-2%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$0.00

Shares Outstanding

5.96M

Volume

2

Avg. Volume

90.127

Financials (TTM)

Gross Profit

$1.07M

Operating Income

$37.01M

EBITDA

$36.43M

Operating Cash Flow

$32.14M

Capital Expenditure

$244.86K

Free Cash Flow

$32.38M

Cash & ST Invst.

$12.30M

Total Debt

$6.17M

OncoSec Medical Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2023YOY CHG

Revenue

$0.00

N/A

Gross Profit

$62.46K

N/A

Gross Margin

0.00%

N/A

Market Cap

$0.00

N/A

Market Cap/Employee

N/A

N/A

Employees

40

N/A

Net Income

$6.86M

+30.8%

EBITDA

$6.81M

+29.0%

Quarterly Fundamentals

Name
Q2 2023YOY CHG

Net Cash

$219.12K

-98.8%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$2.13M

-54.8%

Short Term Debt

$1.34M

-12.8%

Return on Assets

-1.56%

N/A

Return on Invested Capital

-2.43%

N/A

Free Cash Flow

$6.63M

+33.8%

Operating Cash Flow

$6.61M

+34.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
MTSTMetaStat, Inc.
$0.00+0.00%
ROSGQRosetta Genomics Ltd.
$0.00+0.00%
ATRXAdhera Therapeutics, Inc.
$0.00+0.00%
MODCModern Technology Corp.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
CNSPCns Pharmaceuticals
$9.14+2.95%
GBTGGlobal Business Travel Group
$9.35+0.58%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$13.11+0.00%
SOUNSoundHound AI
$9.77+0.02%

Questions About ONCSQ

What is the current price of OncoSec Medical?

OncoSec Medical is trading at N/A per share.

What is the 52-week range for OncoSec Medical?

Over the past 52 weeks, OncoSec Medical has traded between N/A and $0.00.

How much debt does OncoSec Medical have?

As of the most recent reporting period, OncoSec Medical reported total debt of $6.17M.

How much cash does OncoSec Medical have on hand?

OncoSec Medical reported $12.30M in cash and cash equivalents in its most recent financial results.

What is OncoSec Medical’s dividend yield?

OncoSec Medical does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.